Do Ultraprocessed Foods Increase Lupus Risk for Women?

Published Date: 12 Jul 2024

Sobering findings from Nurses' Health Study

Read Full News

Latest News

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial

Spotlighting Updates in Psoriasis, PsA Management in 2026, With Philip Mease, MD

FDA News Recap: Novel Drug Approvals in Q2 2026

FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis

Why Has This Young Man Lost the Ability to Squat and Clench His Fists?

Joint stiffness is just one symptom of this rare debilitating inflammatory disease

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial

Spotlighting Updates in Psoriasis, PsA Management in 2026, With Philip Mease, MD

FDA News Recap: Novel Drug Approvals in Q2 2026

FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis

Joint stiffness is just one symptom of this rare debilitating inflammatory disease

News All Time

Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis

Clinicians consider many differentials

Optimizing the Diagnosis and Care of Sjögren's Disease: Real-World Perspectives From Patients and Clinicians

Evolving Frontiers in Systemic Lupus Erythematosus: Bridging Pathophysiology and Practice

Competition Builds for Novel IgA Nephropathy Approach

Second agent targeting BAFF and APRIL appears effective in phase III trial

Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Don't Blame DMARDs for Adverse Drug Effects in Rheumatology Patients

Study finds most complaints arise from other meds such as antacids and antibiotics

Pictorial Tool Helps Lupus Patients Stay on Hydroxychloroquine

Decision aid clarifies benefits and risks; trial shows it improved adherence

Serology Affects Transition From Arthralgia to Full-Blown Rheumatoid Arthritis

ACPA status could inform treatment and preventive strategies

CAR T-Cell Trial in Rheumatoid Arthritis Starts Off Strong

Strong initial responses in 4 of 6 patients after many standard drugs had failed

Novel Biologic Performs Well in IgG4-Related Disease

Developers hope its dual mechanism will help it outdo the only currently approved therapy

Big Win for Secukinumab in Polymyalgia Rheumatica

Failed trial in giant cell arteritis also published the same day

Novel Concept, 'Immune Dimming,' Explored in Rheumatoid Arthritis

Pilot study finds partial B-cell depletion restores DMARD responsiveness

Late-Breaking Studies at EULAR Paint Rosy Picture of Rheumatology's Future

Psoriatic arthritis biologics square off, novel molecules and mechanisms, and old drugs made new

Post-Marketing Studies Document Extra VTE Risk for Baricitinib

Beefed up label warning now appears likely, though events still rare

Four-Year Data Confirm Anifrolumab Efficacy in Lupus

Study focuses on interferon blocker's hematologic and serologic benefits

Shingles Vaccine Might Be Less Effective in Systemic Sclerosis Patients

Prospective trial shows reduced immune response but no worsening of underlying disease

Do Ultraprocessed Foods Increase Lupus Risk for Women?

Latest News

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial

Spotlighting Updates in Psoriasis, PsA Management in 2026, With Philip Mease, MD

FDA News Recap: Novel Drug Approvals in Q2 2026

FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis

Why Has This Young Man Lost the Ability to Squat and Clench His Fists?

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Latest News

News All Time

Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis

Optimizing the Diagnosis and Care of Sjögren's Disease: Real-World Perspectives From Patients and Clinicians

Evolving Frontiers in Systemic Lupus Erythematosus: Bridging Pathophysiology and Practice

Competition Builds for Novel IgA Nephropathy Approach

Care for Adults with Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Don't Blame DMARDs for Adverse Drug Effects in Rheumatology Patients

Pictorial Tool Helps Lupus Patients Stay on Hydroxychloroquine

Serology Affects Transition From Arthralgia to Full-Blown Rheumatoid Arthritis

CAR T-Cell Trial in Rheumatoid Arthritis Starts Off Strong

Novel Biologic Performs Well in IgG4-Related Disease

Big Win for Secukinumab in Polymyalgia Rheumatica

Novel Concept, 'Immune Dimming,' Explored in Rheumatoid Arthritis

Late-Breaking Studies at EULAR Paint Rosy Picture of Rheumatology's Future

Post-Marketing Studies Document Extra VTE Risk for Baricitinib

Four-Year Data Confirm Anifrolumab Efficacy in Lupus

Shingles Vaccine Might Be Less Effective in Systemic Sclerosis Patients

Recommended News For You

Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

Q&A: Nipple-Sparing Mastectomy After Breast Radiation

The Kansas Cancer Center awarded two Indian American doctors professorships.

More Evidence Ties Microplastics to Lung Cancer

QOL Maintained With Giredestrant Combo in Advanced BC

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

Recommended Articles For You

Treating Methemoglobinemia: What You Need to Know Now!

The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence

Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.